First and foremost among these recommendations is that the CINV risk for every patient should be assessed before chemotherapy is administered,and appropriate prophylactic measure should be taken, based on the latest guidelines.
It is clear that the implementation of our recommendations must take account of the healthcare and professional cultures in each country. However,we believe that the formation of the forum and our commitment to ongoing discussions and activity will help to improve cross-border communication of knowledge, idea and good practice, and raise the profile of an evidence -based approach to CINV management.